Manulife (Manufacturers Life Insurance)’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,579
| Closed | -$117 | – | 3204 |
|
|
2021
Q4 | $117 | Buy |
3,579
+154
| +4% | +$5 | ﹤0.01% | 3035 |
|
|
2021
Q3 | $153K | Sell |
3,425
-228
| -6% | -$10.2K | ﹤0.01% | 3062 |
|
|
2021
Q2 | $199K | Buy |
3,653
+812
| +29% | +$44.2K | ﹤0.01% | 3108 |
|
|
2021
Q1 | $212K | Buy |
2,841
+233
| +9% | +$17.4K | ﹤0.01% | 2851 |
|
|
2020
Q4 | $283K | Buy |
2,608
+82
| +3% | +$8.9K | ﹤0.01% | 2554 |
|
|
2020
Q3 | $223K | Hold |
2,526
| – | – | ﹤0.01% | 2499 |
|
|
2020
Q2 | $266K | Buy |
2,526
+209
| +9% | +$22K | ﹤0.01% | 2333 |
|
|
2020
Q1 | $137K | Buy |
2,317
+163
| +8% | +$9.64K | ﹤0.01% | 2478 |
|
|
2019
Q4 | $149K | Sell |
2,154
-108
| -5% | -$7.47K | ﹤0.01% | 2692 |
|
|
2019
Q3 | $236K | Sell |
2,262
-104
| -4% | -$10.9K | ﹤0.01% | 2468 |
|
|
2019
Q2 | $219K | Buy |
2,366
+1,347
| +132% | +$125K | ﹤0.01% | 2584 |
|
|
2019
Q1 | $93K | Buy |
+1,019
| New | +$93K | ﹤0.01% | 2585 |
|
|
2018
Q4 | – | Sell |
-1,036
| Closed | -$123K | – | 2861 |
|
|
2018
Q3 | $123K | Sell |
1,036
-1,007
| -49% | -$120K | ﹤0.01% | 2877 |
|
|
2018
Q2 | $208K | Buy |
2,043
+751
| +58% | +$76.5K | ﹤0.01% | 3106 |
|
|
2018
Q1 | $168K | Buy |
1,292
+969
| +300% | +$126K | ﹤0.01% | 3143 |
|
|
2017
Q4 | $32K | Sell |
323
-364
| -53% | -$36.1K | ﹤0.01% | 3666 |
|
|
2017
Q3 | $101K | Sell |
687
-369
| -35% | -$54.2K | ﹤0.01% | 3323 |
|
|
2017
Q2 | $170K | Buy |
1,056
+1,047
| +11,633% | +$169K | ﹤0.01% | 3143 |
|
|
2017
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 4099 |
|
|
2016
Q4 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 4247 |
|